Nexus AG
XETRA:NXU

Watchlist Manager
Nexus AG Logo
Nexus AG
XETRA:NXU
Watchlist
Price: 69.5 EUR -0.57% Market Closed
Market Cap: 1.2B EUR
Have any thoughts about
Nexus AG?
Write Note
Section:
 

Relative Value

The Relative Value of one NXU stock under the Base Case scenario is 66.03 EUR. Compared to the current market price of 69.5 EUR, Nexus AG is Overvalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NXU Relative Value
Base Case
66.03 EUR
Overvaluation 5%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.6
P/S
P/S
Price to Sales
4.6
vs History
33
vs Industry
32
Median 3Y
4.2
Median 5Y
4.2
Industry
2.3
Forward
4.3
More Details
44.8
P/E
P/E
Price to Earnings
44.8
vs History
63
vs Industry
13
Median 3Y
42.8
Median 5Y
47.7
Industry
23.1
Forward
37
More Details
41.4
P/OCF
P/OCF
Price to OCF
41.4
vs History
0
vs Industry
13
Median 3Y
29.1
Median 5Y
28.7
Industry
14.2
More Details
78.2
P/FCFE
P/FCFE
Price to FCFE
78.2
vs History
14
vs Industry
7
Median 3Y
54.8
Median 5Y
53.3
Industry
20.1
More Details
4.5
P/B
P/B
Price to Book Value
4.5
vs History
53
vs Industry
23
Median 3Y
3.9
Median 5Y
4.8
Industry
2.2
More Details
4.2
EV/S
EV/S
Enterprise Value to Sales
4.2
vs History
34
vs Industry
33
Median 3Y
3.8
Median 5Y
4
Industry
2.4
Forward
4
More Details
4.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.9
vs History
36
vs Industry
50
Median 3Y
4.5
Median 5Y
4.6
Industry
5
More Details
19.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.5
vs History
34
vs Industry
21
Median 3Y
17.9
Median 5Y
17.9
Industry
12.7
Forward
18.7
More Details
29.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
29.5
vs History
53
vs Industry
16
Median 3Y
28
Median 5Y
29.4
Industry
17.1
Forward
27.5
More Details
37.8
EV/OCF
EV/OCF
Enterprise Value to OCF
37.8
vs History
4
vs Industry
15
Median 3Y
26.2
Median 5Y
26.4
Industry
14
More Details
52.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
52.1
vs History
3
vs Industry
13
Median 3Y
35
Median 5Y
34.6
Industry
18
More Details
3.7
EV/IC
EV/IC
Enterprise Value to IC
3.7
vs History
39
vs Industry
28
Median 3Y
3.5
Median 5Y
3.6
Industry
1.9
More Details

Multiples Across Competitors

NXU Competitors Multiples
Nexus AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Nexus AG
XETRA:NXU
1.2B EUR 4.6 44.8 19.5 29.5
US
Veeva Systems Inc
NYSE:VEEV
36.1B USD 13.7 54.5 45.9 48.6
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
26.7B AUD 160.4 322.2 225.5 225.5
US
Doximity Inc
NYSE:DOCS
10.7B USD 20.9 62.2 46.8 49.2
US
Waystar Holding Corp
NASDAQ:WAY
6.3B USD 7 -120.2 24.7 68.8
JP
M3 Inc
TSE:2413
934B JPY 3.8 23.9 11.8 13.8
US
Inspire Medical Systems Inc
NYSE:INSP
5.5B USD 7.3 166 277.3 377.8
SE
Sectra AB
STO:SECT B
53.5B SEK 29.5 119.5 -71.4 -71.4
US
Vocera Communications Inc
F:V00
2.4B EUR 10.7 -294.8 239.5 3 835.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
16.2B CNY 5.1 45.1 32.4 32.4
P/E Multiple
Earnings Growth P/E to Growth
DE
Nexus AG
XETRA:NXU
Average P/E: 99
44.8
80%
0.6
US
Veeva Systems Inc
NYSE:VEEV
54.5
142%
0.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
322.2
131%
2.5
US
Doximity Inc
NYSE:DOCS
62.2
78%
0.8
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -120.2 N/A N/A
JP
M3 Inc
TSE:2413
23.9
33%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
166
N/A N/A
SE
Sectra AB
STO:SECT B
119.5
81%
1.5
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -294.8 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
45.1
142%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
Nexus AG
XETRA:NXU
Average EV/EBITDA: 94.5
19.5
43%
0.5
US
Veeva Systems Inc
NYSE:VEEV
45.9
221%
0.2
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225.5
130%
1.7
US
Doximity Inc
NYSE:DOCS
46.8
92%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
24.7
N/A N/A
JP
M3 Inc
TSE:2413
11.8
24%
0.5
US
Inspire Medical Systems Inc
NYSE:INSP
277.3
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.4 N/A N/A
US
V
Vocera Communications Inc
F:V00
239.5
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32.4
143%
0.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
Nexus AG
XETRA:NXU
Average EV/EBIT: 472.4
29.5
61%
0.5
US
Veeva Systems Inc
NYSE:VEEV
48.6
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225.5
122%
1.8
US
Doximity Inc
NYSE:DOCS
49.2
102%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
68.8
N/A N/A
JP
M3 Inc
TSE:2413
13.8
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
377.8
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.4 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 835.2
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32.4
123%
0.3

See Also

Summary
NXU intrinsic value, competitors valuation, and company profile.
DCF Valuation
NXU stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NXU stock valuation using valuation multiples.
Wall Street Estimates
NXU price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NXU stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.